Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Specialties
Publications
Articles from Nancy Dvorin:
Read all from this author
Perspective & Commentary

Digital Edition: MedTech Strategist May 2026

  • 2026-05-01 00:00:00.0
  • Nancy Dvorin
  • MedTech Strategist

Gender-specific therapies improve both patient care and ROI for investors and developers, but necessary data isn't being collected today. The phased-in elimination of the inpatient-only rule and the migration of procedures to ASCs are forcing medtechs to rethink where and how much they get paid; Common mistakes that kill start-ups; Can a disciplined screening criteria improve angel investing outcomes? Plus profiles of Argá Medtech, Nephrodite, and SleepRes.

Read Article